Difference between revisions of "Talk:Oroboros Diagnostics"
From Bioblast
Line 34: | Line 34: | ||
=== Participants ===ย ย | === Participants ===ย ย | ||
[[File:Acmit Logo.jpg|right|200px|ACMIT]] | [[File:Acmit Logo.jpg|right|200px|ACMIT]] | ||
:::: '''ACMIT GmbH''' - Austrian Center for Medical Innovation and Technology - [https://acmit.at/ www.acmit.at] | :::: '''ACMIT GmbH''' - Austrian Center for Medical Innovation and Technology - [https://acmit.at/ www.acmit.at] | ||
::::* ACMIT is a COMET Center (K1) funded within COMET โ Competence Centers for Excellent Technologies โ by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by [[www.ffg.at/comet | FFG]]. ย | ::::* ACMIT is a COMET Center (K1) funded within COMET โ Competence Centers for Excellent Technologies โ by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by [[www.ffg.at/comet | FFG]]. ย |
Revision as of 08:34, 19 October 2022
Talk:Oroboros Diagnostics
Oroboros Diagnostics - instrumental innovation to diagnostic standard
Oroboros Diagnostics
- COMET Center (K1) - eCall - Project No. 47281252
- Duration: 18-24 months
- Start: tbc
About Oroboros Diagnostics
- Oroboros Diagnostics will be established as a new branch (GmbH) with a business plan to launch an 8-chamber medical device (O8k) for mitochondrial diagnostics. The O8k as a medical device is required for clinical use, with simplifications (O2 measurement only) and specific optimizations (e.g. optical sensor) compared to the general research instrument O2k. A medical device requires an organizational platform separate from the research-linked model of Oroboros Instruments.
Aims
- Instrumental development and market launch of O8k as a research device for applications by early testers.
- Formulation and creation of basic documents to start an ISO 13485-compliant product development for medical device. Formulation of a project plan including milestone plan and budget calculation up to CE approval.
- Instrumental development advancement of O8k as a medical device for broader application of mitochondrial diagnostics. Potential development of titration robotics to offer the O8k as a Unified Endpoint Management system.
References
Coordinator
- Carolina Gnaiger - Oroboros project management
Network
Participants
- ACMIT GmbH - Austrian Center for Medical Innovation and Technology - www.acmit.at
- ACMIT is a COMET Center (K1) funded within COMET โ Competence Centers for Excellent Technologies โ by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by FFG.
- The research and development center operates in the field of medical technology and has a bridging function between requirements at clinical side, basic research in medical technology at academic side and the development, implementation of products at company side.
- DI Bernhard Nuรbaumer, MAS, EMBA - Chief Business Development Officer
- ACMIT GmbH - Austrian Center for Medical Innovation and Technology - www.acmit.at
- Oroboros Instruments GmbH - www.oroboros.at
- Erich Gnaiger, Ph.D. - PI
- Sabine Schmitt, Ph.D
- Verena Laner - Oroboros project management
- Carolina Gnaiger - Oroboros project management
- Oroboros Instruments GmbH - www.oroboros.at
Oroboros project involvement
- Oroboros Instruments is a partner in the network of ACMIT GmbH - Austria Center for Medical Innovation and Technology.
Oroboros Diagnostics Events
Oroboros Diagnostics Publications
Links
News and articles
Support
- This project has received funding from the Austrian Research Promotion Funding Agency (FFG).